低营养风险胃癌术后患者恶病质预后模型的开发与验证:双中心回顾性队列研究
该双中心回顾性队列研究纳入1393例开发队列和501例外部队列,构建含12个因素的胃癌术后恶病质预测模型并绘制列线图。模型在训练集、内部验证集和外部队列的AUC分别为0.805、0.767和0.795,校准曲线一致性高,决策曲线分析显示临床实用价值。
要点
- 模型含12个因素,包括年龄、术前BMI、手术类型、化疗、分期、吻合口梗阻、PGS、白蛋白、血红蛋白、甘油三酯、CRP和NLR。
- 训练集AUC为0.805,内部验证集为0.767,外部队列为0.795,区分能力良好。
- 校准曲线显示预测概率与实际概率高度一致,决策曲线分析支持临床实用性。
核心结论
- 成功开发并验证了胃癌术后恶病质预测模型,可帮助临床医生准确评估术后营养缺乏患者的恶病质风险。
研究设计与样本
- 双中心回顾性队列研究,队列1(n=1393)为开发队列,队列2(n=501)为外部验证队列。
- 队列1中70%用于模型训练,30%用于内部验证,训练集先进行单因素logistic回归,再进行多因素logistic回归。
主要发现
- 模型纳入12个因素:年龄(OR=1.07)、术前BMI(OR=0.89)、全胃切除术(OR=1.83)、化疗(OR=1.52)、III期(OR=1.40)、吻合口梗阻(OR=6.85)、PGS(OR=2.27)、白蛋白(OR=0.95)、血红蛋白(OR=0.98)、甘油三酯(OR=0.36)、CRP(OR=1.07)、NLR(OR=1.05)。
- ROC曲线AUC在训练集为0.805,内部验证集为0.767,外部队列为0.795。
- 校准曲线在三个数据集中均显示实际与预测概率高度一致,决策曲线分析表明模型在三个数据集中均有 substantial 临床效用。
临床怎么用
- 可利用该模型评估胃癌术后患者恶病质风险,及时进行营养干预以改善生活质量和预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gastric cancer can lead to excessive catabolism in patients. After undergoing gastric surgery, patients may experience additional unintended weight loss, resulting in severe malnutrition and potentially cachexia. METHODS: We selected and incorporated patients from two centers. Cohort 1 (n = 1393) served as the development cohort, while cohort 2 (n = 501) was designated as an external validation cohort. Within cohort 1, 70% of the patients were utilized for model training, with the remaining 30% reserved for internal validation. The training set initially underwent univariate logistic regression, followed by multivariate logistic regression. The factors ultimately incorporated were used to construct the model and create nomograms. The discriminative ability was assessed using ROC curves in all three datasets, calibration curves were used to evaluate consistency, and decision curves analysis was performed to assess the clinical application value. RESULTS: The model incorporated 12 factors, specifically: age (OR = 1.07), preoperative BMI (OR = 0.89), surgery type (Total Gastrectomy (TG), OR = 1.83), chemotherapy (yes, OR = 1.52), stage (III, OR = 1.40), anastomotic obstruction (yes, OR = 6.85), Postsurgical Gastroparesis Syndrome (PGS) (yes, OR = 2.27), albumin (OR = 0.95), hemoglobin (OR = 0.98), triglycerides (OR = 0.36), CRP (OR = 1.07), and Neutrophil to Lymphocyte Ratio (NLR) (OR = 1.05). The model demonstrated robust performance in ROC with AUC values of 0.805 in the training set, 0.767 in the validation set, and 0.795 in Cohort 2. Calibration curves in all three datasets exhibited a high degree of concordance between actual and predicted probabilities. Decision curve analysis (DCA) indicated that the model holds substantial clinical utility across all three datasets. CONCLUSIONS: We have developed a predictive model for cachexia in patients undergoing gastric cancer surgery. This model enables healthcare professionals to accurately estimate the risk of cachexia in postoperative patients with nutritional deficits, allowing for timely nutritional interventions to enhance patient quality of life and prognosis.
引用
- Zhang C, Fu Y, Sun Y, et al. Development and validation of a prognostic model for cachexia in postoperative gastric cancer patients with low nutritional risk: a dual-center retrospective cohort study. Surg Endosc. 2024. PMID: 39500769. doi:10.1007/s00464-024-11367-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。